Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-028828
Filing Date
2015-05-08
Accepted
2015-05-08 16:31:12
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v409470_10q.htm 10-Q 245426
2 EXHIBIT 31.01 v409470_ex31-01.htm EX-31.01 9072
3 EXHIBIT 31.02 v409470_ex31-02.htm EX-31.02 9078
4 EXHIBIT 32.01 v409470_ex32-01.htm EX-32.01 6082
  Complete submission text file 0001144204-15-028828.txt   3278271

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT tnxp-20150331.xml EX-101.INS 358133
6 XBRL TAXONOMY EXTENSION SCHEMA tnxp-20150331.xsd EX-101.SCH 45425
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tnxp-20150331_cal.xml EX-101.CAL 25160
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tnxp-20150331_def.xml EX-101.DEF 257131
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tnxp-20150331_lab.xml EX-101.LAB 291598
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tnxp-20150331_pre.xml EX-101.PRE 282407
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36019 | Film No.: 15847250
SIC: 2834 Pharmaceutical Preparations